Raphaëlle Orès
YOU?
Author Swipe
View article: Challenges in posterior uveitis—tips and tricks for the retina specialist
Challenges in posterior uveitis—tips and tricks for the retina specialist Open
Purpose Posterior uveitis is a common chorioretinal pathology affecting all ages worldwide and is a frequent reason for referral to the retina clinic. The spectrum of etiologies for uveitis is very broad and includes infectious and auto-im…
View article: Relentless placoid chorioretinitis: A review of four cases in pediatric and young adult patients with a discussion of therapeutic strategies
Relentless placoid chorioretinitis: A review of four cases in pediatric and young adult patients with a discussion of therapeutic strategies Open
Introduction Relentless placoid chorioretinitis (RPC) is a rare, bilateral disease of the retinal pigment epithelium. The clinical course is prolonged and relapsing. No standard treatment has been established to date. The purpose of this c…
View article: Didanosine-induced Retinopathy: New Insights with Long-term Follow-up
Didanosine-induced Retinopathy: New Insights with Long-term Follow-up Open
We propose new guidelines including early screening and long-term observations.
View article: Review of the Current Literature and Our Experience on the Value of OCT-angiography in White Dot Syndromes
Review of the Current Literature and Our Experience on the Value of OCT-angiography in White Dot Syndromes Open
We confirmed that OCT-A contributes new information on the physiopathology of white dot syndromes and inflammatory chorioretinopathies, notably on whether or not the choriocapillaris is involved. Comparing the OCT-A features allowed us to …
View article: Comparative Biochemical Outcomes, Effectiveness and Tolerance of Densiron 68 and Oxane HD for the Management of Complicated Retinal Detachment
Comparative Biochemical Outcomes, Effectiveness and Tolerance of Densiron 68 and Oxane HD for the Management of Complicated Retinal Detachment Open
Densiron® 68 appears to be more effective than Oxane® HD for the management of RD associated with PVR. A randomized, controlled, interventional study is needed to demonstrate this difference.